PYC 0.00% 17.0¢ pyc therapeutics limited

Ann: PYC Expands US Executive Leadership Team, page-11

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,374 Posts.
    lightbulb Created with Sketch. 692
    I guess we still wait for an answer to "does it work". But it does at least seem they have massively improved the chances by deciding to target these eye diseases rather than more generalised parts of the body such as muscles. I'm "still" no scientist but targeting areas within the eye at least initially with the cell penetrative treatments seemed like a great way to limit off target absorption. Also seems like a much smaller and more specific target they have chosen so I am assuming they get more effect in more specific required area than if they were trying to treat something in the general body mass?
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Last
17.0¢
Change
0.000(0.00%)
Mkt cap ! $793.2M
Open High Low Value Volume
17.0¢ 17.3¢ 16.5¢ $127.4K 753.0K

Buyers (Bids)

No. Vol. Price($)
13 319876 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 27378 2
View Market Depth
Last trade - 13.43pm 08/10/2024 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.